Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBank Of Ireland Regulatory News (BIRG)

  • There is currently no data for BIRG

2017 Supervisory Review and Evaluation Process

19 Dec 2017 09:45

RNS Number : 7719Z
Bank of Ireland Group PLC
19 December 2017
 

Bank of Ireland Group plc (together with its subsidiaries, the ''Group'')

 

Update on ECB Supervisory Review and Evaluation Process

 

19 December 2017

 

The Group has been notified of the European Central Bank's final decision on the Group's own funds requirements applicable from 1 January 2018 following the 2017 Supervisory Review and Evaluation Process (''SREP'') and the overall outcome is in line with the current year.

 

The Group is required to maintain a Common Equity Tier 1 ("CET 1") ratio of 8.625% on a transitional basis from 1 January 2018. This includes a Pillar 1 Requirement of 4.50%, an unchanged Pillar 2 Requirement of 2.25%, and an increase of 0.625% in the Capital Conservation Buffer to 1.875% (reflecting a further year's phase-in). The Group's Pillar 2 Guidance, which is not disclosed, has been adjusted such that the overall capital requirement from the ECB (i.e. inclusive of the Pillar 2 Guidance) is in line with the current year. The Pillar 2 Guidance is not relevant for the Maximum Distributable Amount (MDA).

 

This requirement compares to the Group's reported transitional CET 1 ratio of 14.7% at the end of September 2017.

 

Ends

 

For further information please contact:

 

Bank of Ireland

 

Andrew Keating Group Chief Financial Officer +353 (0)766 23 5141

Alan Hartley Director of Group Investor Relations +353 (0)766 23 4850

Pat Farrell Head of Group Communications +353 (0)766 23 4770

 

Appendix - Additional Information

 

ECB SREP Requirements for 2018

Pillar 1 - CET1

4.50%

Pillar 2 Requirement (P2R)

2.25%

Capital Conservation Buffer (CCB)

1.875%

Total CET1(i) (ii) (iii) / MDA Trigger (ii) (iii)

8.625%

Pillar 1 - Tier 1

1.5%

Total Tier 1

10.125%

Pillar 1 - Tier 2

2.0%

Total Capital

12.125%

 

 

(i) Does not include Pillar 2 Guidance, which is not disclosed in accordance with regulatory preference

 

(ii) Excludes Other Systemically Important Institutions Buffer (O-SII) which commences phase-in at 0.5% per annum from July 2019 (increasing to 1.5% by July 2021)

 

(iii) Excludes the expected impact of the UK Countercyclical Buffer (CCyB) of c.0.15% applicable from 27 June 2018, rising to c.0.3% from 28 November 2018. The expected impact reflects the phase-in of the UK CCyB to UK exposures as announced by the Financial Policy Committee on 28 November 2017 and applied in proportion to UK risk weighted assets (RWA) in the Group's balance sheet.

 

 

 

Forward Looking Statement

 

This announcement contains certain forward-looking statements with respect to certain of the Group's plans and its current goals and expectations relating to its future financial condition and performance, the markets in which it operates, and its future capital requirements. These forward-looking statements often can be identified by the fact that they do not relate only to historical or current facts. Generally, but not always, words such as 'may,' 'could,' 'should,' 'will,' 'expect,' 'intend,' 'estimate,' 'anticipate,' 'assume,' 'believe,' 'plan,' 'seek,' 'continue,' 'target,' 'goal', 'would,' or their negative variations or similar expressions identify forward-looking statements, but their absence does not mean that a statement is not forward looking. Examples of forward-looking statements include among others, statements regarding the Group's near term and longer term future capital requirements and ratios, loan to deposit ratios, expected impairment charges, the level of the Group's assets, the Group's financial position, future income, business strategy, projected costs, margins, estimates of capital expenditures, discussions with Irish, United Kingdom, European and other regulators and plans and objectives for future operations.

 

Nothing in this announcement should be considered to be a forecast of future profitability, dividends or financial position and none of the information in this document is or is intended to be a profit forecast, profit estimate or dividend forecast. Any forward-looking statement speaks only as at the date it is made. The Group does not undertake to release publicly any revision to these forward-looking statements to reflect events, circumstances or unanticipated events occurring after the date hereof.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCKKLBFDLFXFBL
Date   Source Headline
24th Sep 20257:00 amRNSTransaction in Own Shares
23rd Sep 20257:00 amRNSTransaction in Own Shares
22nd Sep 20257:00 amRNSTransaction in Own Shares
19th Sep 20257:00 amRNSTransaction in Own Shares
18th Sep 20257:00 amRNSTransaction in Own Shares
17th Sep 20257:00 amRNSTransaction in Own Shares
16th Sep 20257:00 amRNSTransaction in Own Shares
15th Sep 20257:00 amRNSTransaction in Own Shares
12th Sep 20257:00 amRNSTransaction in Own Shares
11th Sep 20257:00 amRNSTransaction in Own Shares
10th Sep 20253:01 pmRNSHolding(s) in Company
10th Sep 20257:00 amRNSTransaction in Own Shares
9th Sep 20257:00 amRNSTransaction in Own Shares
8th Sep 20257:00 amRNSTransaction in Own Shares
5th Sep 20259:58 amRNSDirector/PDMR Shareholding
5th Sep 20257:00 amRNSTransaction in Own Shares
4th Sep 20253:38 pmRNSHolding(s) in Company
4th Sep 20257:00 amRNSTransaction in Own Shares
3rd Sep 20257:00 amRNSTransaction in Own Shares
2nd Sep 20257:00 amRNSTransaction in Own Shares
1st Sep 202510:41 amRNSTotal Voting Rights
1st Sep 20257:00 amRNSTransaction in Own Shares
29th Aug 20257:00 amRNSTransaction in Own Shares
28th Aug 20257:00 amRNSTransaction in Own Shares
27th Aug 20257:00 amRNSTransaction in Own Shares
26th Aug 20257:00 amRNSTransaction in Own Shares
22nd Aug 20255:05 pmRNSTransaction in Own Shares
22nd Aug 20257:00 amRNSTransaction in Own Shares
21st Aug 20257:00 amRNSTransaction in Own Shares
20th Aug 20257:00 amRNSTransaction in Own Shares
19th Aug 20257:00 amRNSTransaction in Own Shares
18th Aug 202511:49 amRNSIssuer Call Notice
18th Aug 20257:00 amRNSTransaction in Own Shares
15th Aug 20257:00 amRNSTransaction in Own Shares
14th Aug 20257:00 amRNSTransaction in Own Shares
13th Aug 20257:00 amRNSTransaction in Own Shares
12th Aug 20257:00 amRNSTransaction in Own Shares
11th Aug 20257:00 amRNSTransaction in Own Shares
8th Aug 20255:25 pmRNSDirector/PDMR Shareholding
8th Aug 20257:00 amRNSTransaction in Own Shares
7th Aug 20257:00 amRNSTransaction in Own Shares
6th Aug 20257:00 amRNSTransaction in Own Shares
5th Aug 20257:00 amRNSTransaction in Own Shares
4th Aug 20257:00 amRNSTransaction in Own Shares
1st Aug 20256:22 pmRNS2025 EU-Wide Stress Results
1st Aug 20259:54 amRNSTotal Voting Rights
1st Aug 20257:00 amRNSTransaction in Own Shares
31st Jul 20257:00 amRNSTransaction in Own Shares
30th Jul 20257:00 amRNSTransaction in Own Shares
29th Jul 202512:09 pmRNSInterim Dividend Declaration 2025

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.